
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Remove Advertising filter Advertising (2)
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Complementary medicines (7) Apply Complementary medicines filter
- Remove Disinfectants/Sterilants filter Disinfectants/Sterilants (0)
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Remove Legislation filter Legislation (3)
- Listed medicines (2) Apply Listed medicines filter
- Remove Manufacturing filter Manufacturing (0)
- Medical devices/IVDs (55) Apply Medical devices/IVDs filter
- Remove Medical devices safety filter Medical devices safety (1)
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (5) Apply Prescription medicines filter
- Remove Safety of medicines & medical devices filter Safety of medicines & medical devices (0)
- Scheduling (55) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Advertising filter Advertising
- (-) Remove Medical devices safety filter Medical devices safety
- (-) Remove Safety of medicines & medical devices filter Safety of medicines & medical devices
- (-) Remove Manufacturing filter Manufacturing
- (-) Remove Disinfectants/Sterilants filter Disinfectants/Sterilants
- (-) Remove Legislation filter Legislation
Remaking of standards and legislative instruments for human cell and tissue (HCT) products, blood and blood components
Closed on 11 July 2021
Proposed improvements to the Therapeutic Goods Advertising Code
Closed on 18 June 2021
Standard for vaporiser nicotine (TGO 110)
Closed on 31 March 2021
IMDRF consultation: Proposed update to document on Post-Market Clinical Follow-Up Studies
Closed on 11 December 2020